Smad7基因沉默对细胞增殖的影响

TGF—β是一种多功能的细胞因子,可调节细胞的分化、增殖和凋亡。它对多种上皮细胞尤其是支气管上皮细胞的生长、增殖有很强的抑制作用。Smad7作为TGF—β信号转导通路的抑制分子,可以抑制TGF—β信号在胞浆内的传导。我们以永生化人支气管上皮细胞BEP2D,及恶性转化的BERP35T2细胞为基础所做的研究表明：Smad7基因的表达随细胞恶性度增高而增高,     

黄芪甲苷预处理对无血清及缺氧诱导的骨髓间充质干细胞 TNF-α、TGF-β1基因表达的影响

目的：观察黄芪甲苷预处理对无血清及缺氧诱导的骨髓间充质干细胞（MSCs）凋亡相关因子的影响,并探讨其作用机制。方法采用密度梯度离心法分离培养大鼠 MSCs,通过药物细胞毒性试验检测黄芪甲苷对 MSCs 细胞活性的影响,分别以40、80、160μg / mL 的黄芪甲苷预处理 MSCs 24 h,后进行无血清及缺氧培养24 h,RT-PCR 法检测细胞中 TNF-α、TGF-β1的基因表达情况。结果密度梯度离心法可有效分离大鼠MSCs;各浓度黄芪甲苷对 MSCs 细胞活力均无影响;无血清及缺氧诱导可下调 TGF-β1的基因表达;160μg / mL黄芪甲苷组可上调 TGF-β1的基因表达。结论无血清及缺氧诱导的 MSCs 凋亡可能是由于缺氧及生长因子匮乏的刺激所引起的,黄芪甲苷抑制无血清及缺氧诱导的 MSCs 凋亡的作用可能是通过提高 MSCs 在缺血缺氧环境下合成生长因子的能力实现的。     

重组E.coli. LLO/OVA明显增强小鼠CD11c细胞活性及抗肿瘤免疫

目的 探讨重组E.coli. LLO/OVA 诱导C57BL/6小鼠机体免疫的途径,观察其免疫后小鼠机体抑制B16-OVA黑色素瘤的效果.方法 磁珠分离E.coli. LLO/OVA及E.coli. OVA免疫后小鼠脾脏CD11c、CD4 和CD8 T细胞并检测CD11c细胞诱导同源CD4 和CD8 T增殖水平和细胞因子分泌程度;流式细胞检测小鼠脾脏内肿瘤抗原OVA257-264 SIINFEKL特异的细胞毒T细胞含量.比较两种E.coli. 免疫后,恶性黑色素瘤B16-OVA在小鼠肺内形成瘤结节的数量.结果 与E.coli. OVA相比, E.coli. LLO/OVA免疫后小鼠脾脏CD11c细胞诱导同源CD4 T细胞增殖作用增强、IL-2分泌增高;同时诱导CD8 T细胞增殖和IFN-γ分泌的作用也明显增强;OVA257-264 SIINFEKL特异的CD8 T细胞含量也明显增高;小鼠肺内形成B16-OVA瘤结节平均数明显减少. 结论 E.coli. LLO/OVA有效地诱导小鼠CD11c细胞活化,增强其对CD4 T细胞增殖和IL-2分泌以及对CD8 T细胞增殖、IFN-γ分泌的作用,诱导了更多的OVA特异的CD8 T细胞,使机体产生了更强的抗肿瘤免疫.     

刺壳花椒 HPLC 指纹图谱的研究

目的 采用高效液相色谱法研究并建立了产于张家界的刺壳花椒药材的指纹图谱。方法 Diamonsil C₁₈ 色谱柱 (250 mm×4.6 mm, 5 μm),乙腈-水流动相系统梯度洗脱,体积流量 1.0 mL/min,检测波长 278 nm。结果 对所采集的10批刺壳花椒药材进行了测定,建立了刺壳花椒的指纹图谱,共有11个共有峰。结论 HPLC 法色谱指纹图谱分析技术可用于刺壳花椒药材质量的控制。     

穴位埋线对血管性痴呆大鼠学习记忆能力和Bcl-2表达的影响

目的: 探讨穴位埋线对血管性痴呆(VD)大鼠学习记忆的影响及可能的机制.方法: 改良Pulsinelli's四血管阻断法建立血管性痴呆大鼠模型.造模后给予穴位埋线,用水迷宫检测学习记忆能力,免疫组织化学观察海马Bcl-2的表达.结果: 穴位埋线后VD大鼠学习记忆能力明显提高,海马齿状回Bcl-2表达增强.结论: 穴位埋线改善VD大鼠的学习记忆能力,可能与上调海马Bcl-2的表达、保护缺血后海马神经元有关.     

Reduction of RhoC is involved in the decreased migration of neural stem/precursor cells

OBJECTIVE Alzheimer′s disease(AD) is mainly characterized by a progressive loss of neurons and the deposition of beta-amyloid peptides(Aβ).It was demonstrated that transplanted and endogenous neural stem cells or neural precursor cells can survive,migrate,and differentiate into neurons.Previously we found that Aβ42 could disturb the migratory ability of neural stem/precursor cells.We therefore hypothesized that Aβ42 may affect some important proteins through Rho pathway and result in the decreased migration of neural stem/precursor cells.METHODS AND RESULTS We applied siRNA technology to knock down the expression of RhoC in neural stem/precursor cells and found that the expression of RhoC was down-regulated;Trans well assay was used to measure the migratory ability of the neural stem/precursor cells and the result showed that the migratory ability was disturbed when the expression of RhoC was down-regulated;WRW4 was used for inhibiting the effects of the Aβ42 through the FPRL1.CONCLUSION The reduction of RhoC was involved in the decreased migration of neural stem cells.     

Common features of anaphylaxis in children

ObjectiveWe aimed to establish the characteristics of anaphylaxis in childhood.MethodsForty-four patients who had experienced anaphylaxis in a period of 10 years (from 1999 to 2009), were included in the study. Parameters analysed were age, gender, concomitant allergic disease, trigger, setting, clinical symptoms, treatment, prognosis and prophylaxis.ResultsThe total numbers of anaphylaxis cases were 44 in a ten-year period. The ages of patients ranged from 3 to 14 years (11.50 ± 3.87 years) and the majority were male. 33 of the patients (75%) had a concomitant allergic disease. The trigger was determined in 93.2% of the cases, being most frequent: food (27.3%), and SIT (25%), followed by bee sting, medications and others. Respiratory (95.5%), dermatological (90.9%), cardiovascular (20.5%), neuropsychiatric (25%), and gastrointestinal (11.4%) symptoms were seen most frequently. For anaphylaxis triggered by food, the duration of anaphylactic episode was significantly longer (p < 0.05). No biphasic reaction was observed during these attacks. Of our patients, only one developed respiratory failure and cardiac arrest due to SIT, and intensive care support was required.DiscussionAs a trigger for anaphylaxis, the frequency of SIT is so high that it cannot be described by the study group including patients who were followed up in an outpatient allergy clinic.     

The long-term outcomes of persistent childhood allergic asthma: A cross-sectional study from western Anatolia: Childhood persistent asthma in western Anatolia

BackgroundProspective cohort studies have provided useful knowledge about the natural history of asthma. However, most of the studies are conducted in western countries but the course of the disease and long-term outcomes may differ between countries due to environmental and cultural factors.ObjectiveThe aim of this study is to describe the long-term outcomes of childhood asthma, with data from a follow-up study of at least 10 years, in western Anatolia, Turkey.MethodsFifty-two patients diagnosed with persistent allergic asthma participated in the study. The patient's demographics, findings on admission, age at onset of disease, time of diagnosis, history of other allergic conditions, history of parental asthma and allergic disorders, presence of pharmacotherapy and immunotherapy were obtained from patients’ records. The factors influencing remission at the end of 10 years follow-up were evaluated.ResultsA total of 20 patients (38.5%) were on remission at the end of 10 years. The type of allergen, multi-allergen sensitivity, eosinophilia and elevated serum immunoglobulin E on admission, accompanying allergic disorders and atopy in parents, and allergen immunotherapy did not affect the remission rate (p > 0.05).ConclusionChildhood persistent asthma is not a homogeneous clinical entity but high clinical remission rates are obtained in western Anatolia. There is no significant predictor of clinical remission in long term follow-up. Prospective studies should be performed in larger asthmatic populations to obtain further data about the natural course of childhood asthma.     

Association of β-Thalassemia and Hb Q-Thailand Resulting in a Normal Hb A2 Value

We describe a Chinese woman who was assumed to be a Hb Q-Thailand heterozygote, but was later also shown to have β-thalassemia (β-thal) with a normal amount of Hb A₂.     

Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis

Antisynthetase syndrome (ASS) is characterized by inflammatory muscle disease, pulmonary and joint involvement, and antisynthetase autoantibodies, with anti‐Jo‐1 antibody being the most common. Despite the use of immunosuppressive drugs, the prognosis of lung involvement seems poor. Herein, we report a case of refractory ASS, which maintained long‐term remission by double filtration plasmapheresis (DFPP) combined with immunosuppressive therapy. For a 65‐year‐old woman, who was diagnosed with ASS, immunosuppressive therapy was initiated and plasmapheresis (PP) was performed five times due to acute interstitial pulmonary disease and inflammatory myopathy. She remained in remission for eight months following PP. Increase in interstitial involvement was identified by lung tomography when the patient presented again with complaint of progressive increase in dyspnea and muscle pain. Although the immunosuppressive therapy was increased for the patient with elevated creatine phosphokinase (CPK) (2776 IU/mL), a rapid decrease in diffusion capacity of the lung for carbon monoxide (DLCO) was observed and the patient underwent PP. After four sessions of therapy, insufficient clinical and laboratory response was obtained (control CPK 1797 IU/mL) and because of that issue DFPP using a 2A filter was performed to the patient. There was a marked improvement in complaints of the patient, DLCO, and laboratory findings (control CPK 508 IU/mL) after three sessions of DFPP. The patient, who continued the immunosuppressive therapy after DFPP procedure, is being followed for 12 months in remission. Although our experience is limited with only one patient, DFPP seems promising as a treatment option for ASS with severe lung involvement. J. Clin. Apheresis, 28:422–425, 2013. © 2013 Wiley Periodicals, Inc.